The NHS’s ambitious “Fit for the Future: 10 Year Health Plan for England” outlines a bold vision for the future of healthcare in the country — one that is digitally advanced, community-focused, and prevention-driven. It’s a plan designed to move healthcare from a reactive, hospital-centric model to a proactive, patient-empowering system utilising cutting-edge technologies. Within this transformative agenda, Glooko’s diabetes management platform stands out as an excellent example of how digital health solutions can directly support these crucial goals.

From Analogue to Digital: Empowering Patients and Streamlining Care

At the heart of the NHS’s plan is a commitment to becoming “digital by default.” This means harnessing technology to make healthcare more accessible, efficient, and patient-friendly.

Imagine a world where your health data, whether from your BGM, CGM, insulin pen, or activity tracker, is all in one place. That’s what Glooko offers through its integrations with more than 200 diabetes and health monitoring devices, including wearables, a future standard in the NHS by 2035. By centralising this vital information, it empowers people living with diabetes to take a more active role in managing their diabetes and saves them time by not having to juggle multiple apps or manually record readings.

For healthcare professionals, Glooko centralises health data from their patients into a single platform, helping create the “single, secure and authoritative account of their data” that the NHS aims for. To help reduce time-wasting administrative tasks, streamline workflows, and allow clinicians to have more efficient appointments focused on providing quality care, Glooko is expanding its capability to sync with electronic health record (EHR) systems across England and the rest of Europe. When all the relevant data is at their fingertips and seamlessly flowing between clinical records and the Glooko platform, everyone on the care team, including diabetologists, diabetes specialist nurses, registered dietitians, and general practitioners, can make more informed clinical decisions using our diabetes technology.

With our commitment to safeguarding confidential personal information and handling patient data properly, our diabetes management platform and our company’s practices meet the NHS’s data security standards outlined in the Data Security and Protection Toolkit. We align with the NHS’s requirements for all organisations with access to their patient data and systems.

From Hospital to Community: Enabling Remote Monitoring and Personalised Care

The NHS plan emphasises shifting care away from hospitals and into local communities and even patients’ homes. Glooko is instrumental in making this a reality for diabetes care with its remote patient monitoring capabilities.

This innovative feature of our diabetes software for healthcare providers means fewer trips to the hospital for routine check-ups and more proactive management of diabetes from the comfort of a patient’s home. This not only improves convenience for people living with diabetes but also helps to alleviate pressure on acute hospital services and supports the development of community-based models like “Neighbourhood Health Centres.”

The Glooko connected care platform offers powerful population health analytics. This allows hospitals to view trends and manage their entire patient population more effectively, aligning with the NHS’s goal of preventing illness and managing long-term conditions on a larger scale. The detailed insights provided by Glooko’s data can also support the creation and monitoring of highly personalised care plans, moving closer to the NHS’s goal of offering personal health budgets and tailored support for complex needs like diabetes.

From Sickness to Prevention: Proactive Management and Improved Outcomes

A core tenet of the NHS’s 10 Year Health Plan is a strong focus on prevention and early intervention.

By providing continuous diabetes and related health data and insights, Glooko helps healthcare providers identify potential issues and risks before they escalate. This allows for proactive intervention, which can significantly reduce the likelihood of diabetes-related complications, improving long-term health for patients.

And Glooko isn’t just about data; it’s about demonstrable results. The diabetes management platform has a track record of improving clinical outcomes, including reduced HbA1c levels. These outcomes directly align with the NHS’s aspirations for better health for the population, reduced demand on acute services, and a more sustainable healthcare system.

A Healthier Future for People with Diabetes

We want the NHS 10 Year Health Plan to deliver real improvements for people with diabetes and their care teams. Glooko is more than a diabetes management tool; we’re a strategic partner committed to helping the NHS deliver better care for all patients regardless of wherever they live and whatever they earn.

By accelerating digital transformation, enabling care at home, and championing proactive diabetes management, Glooko is helping build a more efficient, patient-centered, and digitally advanced healthcare system.

With innovative solutions and preferred vendors like Glooko, the NHS is well-equipped to meet the challenges and opportunities ahead as they usher in the future of healthcare in England.

Managing diabetes care has become increasingly complex for clinics, hospitals, and health systems. With a growing number of people living with diabetes relying on multiple devices — glucose meters, continuous glucose monitors (CGMs), insulin pumps, and wearables — healthcare providers face the challenge of piecing together critical data from siloed systems. This fragmentation not only consumes valuable time, but hinders patient care.

At Glooko, we know device integration is the key to solving these challenges and transforming diabetes management. As a market leader in device compatibility, EHR integration, and interoperability, Glooko increases efficiency of clinical workflows by streamlining administrative tasks, enhances patient engagement, and helps deliver better outcomes.

The Challenges of Fragmented Diabetes Management

For healthcare providers, piecing together data from various devices and platforms and apps can feel like an endless puzzle. Without device integrations, clinics and health systems face:

• Disconnected Data: Patient data is scattered across incompatible platforms and apps, making it difficult to understand a patient’s holistic health.
• Inefficient Workflows: Healthcare providers must spend time manually entering or retrieving data instead of focusing their time and expertise to support their patients in achieving better health.
• Limited Patient Engagement: Patients often struggle to track their progress with so many different tools and apps, becoming overwhelmed and losing hope in their ability to make meaningful change.

These challenges contribute to missed opportunities for timely interventions that drive better health outcomes.

How Glooko’s Compatibility Brings Clarity to Diabetes Care

Glooko simplifies diabetes management by integrating data from more than 200 diabetes and health monitoring devices — including Abbott’s FreeStyle Libre CGMs in the U.S. — into a single, user-friendly platform.

Here’s how Glooko’s device compatibility transforms care:

• Data Integration and Interoperability: Glooko consolidates glucose levels, insulin usage, and lifestyle behaviors such as diet and physical activity, giving healthcare providers a holistic view of patient health. Care teams can easily access patient data from a centralized platform.
• Remote Monitoring Capabilities: Healthcare providers can track patient trends and progress between visits, ensuring timely adjustments to care plans and reducing unnecessary appointments and emergency room visits.

Not all devices are available in every country where Glooko is available. The product images are for illustrative purposes only. Not actual patient data. The sensor housing, FreeStyle, Libre, and related brand marks are marks of Abbott and used with permission. Important Safety Information: For full FreeStyle Libre systems safety information, please visit https://www.freestyle.abbott/us-en/safety-information.html.

The Many Benefits of Integration for Clinics, Hospitals, and Health Systems

Our industry-leading device compatibility benefits clinics, hospitals, and health systems by streamlining workflows and improving decision-making through a comprehensive view of patient data. With greater efficiency, care teams can focus more on patient care and expand their reach to serve more individuals in need.

• Streamlined Workflows: Staff spend less time on administrative tasks and more time on what they do best: educating and providing care to their patients.
• Improved Decision-Making: A comprehensive view of patient data allows care teams to create more personalized and effective treatment plans.
• Expanded Clinical Footprint: With more time, clinicians can help more patients in need.

To enable more meaningful data insights, Glooko also seamlessly integrates the health data from their patients’ diabetes and health monitoring devices directly into leading EHR systems, eliminating manual uploads and platform switching and reducing administrative burden.

The Key Benefits of Device Integrations for People Living with Diabetes

Glooko’s device integrations benefit people living with diabetes by simplifying their experience and empowering self-management through centralized data, reducing app overload and supporting informed health decisions.

• Simplified Experience: With integrated data, patients no longer need to juggle multiple apps and passwords, or manually report their glucose levels to their provider.
• Empowered Self-Management: Patients can log meals, exercise, and medications directly in the Glooko app, helping them understand how their choices impact their health.

Proven Results Backed by Global Expertise

Glooko has more than a decade of experience integrating diabetes and health monitoring devices worldwide, supporting millions of people living with diabetes. Glooko’s connected care platform, backed by real-world evidence, delivers the reliability, scalability, and insights clinics, hospitals, and health systems need to stay ahead in diabetes care, setting a new standard.

Simplify Diabetes Care with Glooko

The complexity of diabetes management doesn’t have to hold your clinic, hospital, or health system back. By choosing Glooko, you can eliminate data fragmentation, enhance patient care, and create a more efficient, streamlined experience for healthcare providers and people living with diabetes.

Schedule a personalized demo of our digital health platform today and see how your patients’ health data can be integrated directly into your EHR system.

As a leader in diabetes management, Glooko offers an intelligent connected care platform that allow people with diabetes and their healthcare providers to review, analyze, and evaluate data from many different types of diabetes devices, including blood glucose meters (BGM), continuous glucose monitoring (CGM) systems, insulin pumps, smart pens, and fitness apps.

With Glooko’s digital health solution allowing users to view and analyze CGM and insulin data in one place, we have the ability to work with hybrid closed loop systems, a technology — often known as an artificial pancreas — that automates many of the daily decisions of people living with Type 1 diabetes who use an insulin pump and CGM that communicate with each other.

Innovative hybrid closed loop systems take readings from an individual’s CGM and use an algorithm to automatically tell the insulin pump how much insulin to deliver to keep blood glucose levels stable around the clock.

How Glooko integrates with hybrid closed loop systems

Our digital health platform, used by over 10,000 clinics in more than 30 countries, syncs via the cloud with leading diabetes CGMs and insulin pumps in hybrid closed loop systems to automatically present data around glucose levels, basal rates and more to patients and their care teams via graphically-oriented reports that can help recognize trends, so they can take action to improve their health outcomes.

The hybrid closed loop systems that currently sync with Glooko include:

• mylife Loop (CamAPS FX and Ypsomed)
• Tandem Control-IQ
• Insulet Omnipod 5
• Dana CamAPS® FX

Depending on the brands of the insulin pump and CGM, different methods of syncing via cloud are required to view data in Glooko from hybrid closed loop systems.

Like any great technology, people living with diabetes using a closed loop system still must check to ensure it is working and must count carbohydrates to give the system the correct bolusing data before food consumption. This is where the Glooko Mobile App’s food tracker can be used to track nutrition by searching the food database, using voice capture, or scanning a barcode (in select countries).

Benefits of using hybrid closed loop systems with Glooko

There are many benefits of using hybrid closed loop systems alongside Glooko for patients, including:

• Major changes in treatment that reduce daily burdens and mental stress
• More time with glucose levels in range with less effort
• The ability to visualize blood glucose and insulin data in clear graphs that make it easier to understand automatic boluses and basal rates

There are also many benefits of using hybrid closed loop systems alongside Glooko for care teams, including:

• An increased monitoring of patients with diabetes who are using closed loop systems
• Strengthening their connection with their patients
• Better management of fluctuations in patients’ glucose levels
• Easier interpretation of patient data around basal rate, automatic vs. manual mode and automatic boluses

The future of hybrid closed loop systems

Hybrid closed loop systems in diabetes care are advancing toward more automation, intelligence, and accessibility. These systems are on a path toward becoming fully closed loop systems that will make managing diabetes more automated, adaptive, and accessible, allowing users to focus less on their condition and more on living life.

As the systems evolve, so will Glooko. With the regular introduction of new hybrid closed loop systems, Glooko will continue to partner with leading device manufacturers to integrate their platforms with our digital health solution.

For more information about using a hybrid closed loop system, consult with your healthcare team and explore resources from the Breakthrough T1D, Diabetes UK, and NHS England.

At Glooko, we empower certified diabetes care and education specialists (CDCES) by equipping them with the tools needed to help individuals with Type 1, Type 2, gestational diabetes, and prediabetes better manage their condition and reduce the risk of complications.

Our connected care platform offers remote patient monitoring, compatibility with more than 200 diabetes and health monitoring devices, and easy-to-read reports. With EHR integrations to streamline clinical workflows and population health dashboards, CDCES professionals can proactively identify trends, tailor care plans, and help improve health outcomes — making diabetes care and education more efficient, data-driven, and impactful.

If you’re a CDCES planning to attend the Association of Diabetes Care & Education Specialists’ ADCES25 in Phoenix, Team Glooko wants to meet you at booth #1131 to share the latest updates to our innovative diabetes management platform and mobile app and give you the opportunity to see how we’re transforming diabetes care.

Some of the exciting features and happenings that you can expect to see at our booth:

• Ask An Expert: Our booth will host Glooko Senior Director of Clinical Transformation Trisha Martinez, MBA, RN, BSN, an accomplished clinician, who will share best practices for how CDCESs can educate people living with diabetes to use Glooko to better manage their condition. Our resident clinical expert will be on-site to hear feedback, tips, and tricks for using our connected care platform.
  • Friday, August 8: 9:30-10:15 a.m. and 12:15-2:15 p.m.
  • Saturday, August 9: 9-9:45 a.m., 11:45-1 p.m., and 3-4 p.m.
• Glooko Web and Mobile App: We’ll provide live demos of Glooko, our cutting-edge connected care platform designed to simplify diabetes management and make it easier for people with diabetes to input, view, and understand their health data. Mobile app users can also take advantage of the innovative food tracker feature to easily log their food intake and view their food data alongside data from compatible devices, medications, and exercise. Best of all, the synced data can be securely shared with care teams to stay on track between appointments!
• New Clinic Dashboard: This summer, we’ll launch a new clinic dashboard in Glooko that provides a high-level view of a patient population and program performance across key areas. The Population Metrics panel tracks total patients, CGM use, and activation rates — updated every 14 days — to highlight trends and engagement gaps. CGM Risk Stratification uses CGM data to rank patients by clinical risk, helping prioritize care. Engagement Metrics show where patients are in their onboarding journey and how they sync data, enabling staff to focus outreach and improve engagement efforts.
• EHR Integrations: Glooko seamlessly integrates with leading EHR systems to securely consolidate diabetes data in one place, removing the need to switch platforms or manage multiple logins. This feature allows healthcare providers to work more efficiently within a single interface that offers a comprehensive view of each patient’s health data.
• Latest Device Compatibility: Glooko now integrates with Abbott’s FreeStyle Libre CGMs in the U.S., offering real-time glucose and lifestyle data in one platform, empowering people with diabetes to take better control of their health, and enabling healthcare providers to make more informed, data-driven decisions.

To meet with one of our experts at ADCES25, schedule a meeting.

See you in Phoenix!

The product images are for illustrative purposes only. Not actual patient data. The sensor housing, FreeStyle, Libre, and related brand marks are marks of Abbott and used with permission. Important Safety Information: For full FreeStyle Libre systems safety information, please visit https://www.freestyle.abbott/us-en/safety-information.html.

The Glooko 2025 Global Diabetes Report offers a comprehensive look at how real-world data can drive better outcomes in diabetes care. Powered by billions of data points across 30+ countries, this report uncovers meaningful trends in glycemic management, technology adoption, and behaviors among people living with Type 1, Type 2, and gestational diabetes.

From the rise of remote monitoring to the impact of advanced technologies like Continuous Glucose Monitors (CGMs) and Automated Insulin Delivery (AID) systems, this report explores how personalized insights can be used to better inform personalized care, predict risk, and guide clinical decision-making.

Whether you’re a clinician, researcher, or innovator in diabetes management technology, this report highlights how data can be turned into action — helping to shape a smarter, more connected future of diabetes management.

Download the report

At Glooko, we are committed to simplifying diabetes insights and management for people living with diabetes and healthcare providers alike. That’s why our platform is compatible with more than 200 diabetes and health monitoring devices and growing.

As a company, we could not be more pleased to share that we recently expanded our capabilities to integrate with Abbott’s FreeStyle Libre CGMs in the United States. This integration brings glucose data to more clinics and health systems in our all-in-one solution for diabetes management.

This milestone is more than just a technological advancement — it’s about empowering people with Type 1, Type 2, and gestational diabetes, as well as prediabetes, to become active owners in their health. By combining the precision of Abbott’s FreeStyle Libre CGMs with Glooko’s comprehensive platform, we can provide people living with diabetes and their care teams, including endocrinologists and nurses, with a unified, holistic view of diabetes management and irrefutable information.

From glucose trends to lifestyle behaviors like diet and physical activity, this latest integration ensures that critical insights are easily accessible when and where they are needed most. For healthcare providers and health systems, this means the ability to seamlessly access and analyze patients’ CGM data through Glooko and established electronic health record (EHR) solutions, more informed decision-making, and improved patient outcomes. For people living with diabetes, it means greater confidence in their care and health.

As the number of people with diabetes continues to grow, the need for seamless, data-driven solutions has never been greater. Our new integration with Abbott’s FreeStyle Libre CGMs represents a significant step forward in delivering better, more connected care. This partnership is sure to have a positive impact on the millions of people who rely on FreeStyle Libre CGMs and Glooko.

In the United Kingdom, diabetes technology has rapidly advanced over the past two decades, with platforms like Glooko playing a central role in simplifying care and management.

In honor of Diabetes Week U.K. (9 June to 15), we’re taking a look at the state of diabetes, technology designed to better manage the condition, and the outlook on the evolution of diabetes care and technology.

The State of Diabetes in the United Kingdom

Diabetes is a significant public health concern in the U.K. According to Diabetes U.K., more than 5.8 million people are currently living with the condition. Of these, approximately 4.6 million have been diagnosed and an estimated 1.3 million people may be living with undiagnosed Type 2 diabetes.

Of those diagnosed with diabetes in the U.K., Type 2 diabetes accounts for approximately 90% of cases. While risk factors for Type 1 diabetes include family history and the presence of other autoimmune conditions, Type 2 diabetes risk is heightened obesity, family history, a history of gestational diabetes, specific medications, and other factors.

To address the growing prevalence of diabetes and support those affected, the National Health Service (NHS) offers various education programs aimed at empowering individuals with the knowledge and skills necessary to manage their diabetes effectively, improve health outcomes, and reduce the risk of complications.

For individuals with Type 2 diabetes, programs like DESMOND (Diabetes Education and Self-Management for Ongoing and Newly Diagnosed) and the X-PERT Diabetes Programme provide education on managing the condition through lifestyle changes and self-monitoring. For those with Type 1 diabetes, the DAFNE (Dose Adjustment For Normal Eating) program offers guidance on insulin management and dietary considerations and Digibete helps young people, families, and communities better manage Type 1 diabetes. Additionally, the VICTOR program is designed for adults with Type 2 diabetes who are on insulin therapy and focuses on adjusting insulin doses in response to routine changes.

Diabetes Technology Today

In the U.K., diabetes technology is advancing quickly with Glooko helping streamline data management across compatible diabetes and health monitoring devices, including:

• Hybrid closed loop (HCL) systems, which combine continuous glucose monitoring (CGM) with insulin pumps to automatically adjust insulin delivery based on real-time data.
• Devices like Tandem t:slim X2 require cable downloads, while mylife Loop powered by CamAPS® FX and Omnipod® 5 use cloud-to-cloud integration.
• CGMs provide glucose trends and alerts and are often compatible with pumps and cloud platforms.
• Abbott FreeStyle Libre CGMs data can be seen within Glooko through the upload of data from HCL-compatible insulin pumps.
• Fitness and health monitoring apps can track steps, weight, and blood pressure.
• Smart pens and connected pens allow for remote or in-clinic dose tracking.

Transforming Diabetes Care in the United Kingdom with Glooko

Across the country, more than 85,000 people living with diabetes use Glooko’s digital health platform to manage their diabetes and more than 500 clinics are using Glooko to provide better care to their patients.*

Through our data*, we identified key metrics for time in range for people with Type 1, Type 2, and gestational diabetes in the U.K. using Glooko during 2024.

Today, there is an increased interest in TITR and TIR as a result of the recent technology available for managing diabetes. The Glooko diabetes data management platform helps healthcare providers monitor TIR and TITR to improve glycemic outcomes for people living with diabetes, bringing data from multiple devices into one platform with comprehensive charts and graphs. It ensures consistent data access — even without connected devices — and meets high standards for data protection, including GDPR compliance, to support safe, effective, and standardised diabetes care.

The Future of Diabetes Care in the United Kingdom

The future of diabetes care in the U.K. lies in advancing technology and deeper collaboration. Recent key developments include moving towards fully closed loop systems, integrating AI-enabled personalized insights, and aligning diabetes management with weight loss medications. Continued innovation will help provide more tailored, effective treatment options for people living with diabetes.

Progress also depends on strong partnerships with leading diabetes organisations like the Diabetes Technology Network (DTN-UK) and Diabetes National Networking Forums (NNF).

The future of diabetes care in the U.K. lies in advancing technology and deeper collaboration. Recent key developments include moving towards fully closed loop systems, integrating AI-enabled personalized insights, and aligning diabetes management with weight loss medications. Continued innovation will help provide more tailored, effective treatment options for people living with diabetes.

By showcasing technologies such as hybrid closed loop systems at local events from these leading organisations and through initiatives like our Academy program, a collaboration between Glooko and the Association of British Clinical Diabetologists(ABCD)/DTN-UK providing free education for medical professionals in the U.K., we help educate, support, and empower both clinicians and people living with diabetes across the country.

*Internal Glooko data; based on active Glooko users that synced during 2024

As part of our ongoing commitment to supporting healthcare providers and people living with diabetes, we’re excited to share the latest enhancements and features now available in Glooko Web 25.1 and Mobile 6.11. These updates are designed to streamline workflows, improve patient engagement and security, and provide care teams with more robust tools to manage diabetes care effectively.

Patient Notes and Medications in Week View

Care teams and people living with diabetes can now view notes and medication entries added to the Glooko Mobile and Web App directly in Week View, both online and in PDF reports. These entries appear in a new collapsible “Events” section below each day, making it easier to contextualize trends in glucose data and treatment behaviors.

Streamlined Week View PDF Reports

In our new release, Week View PDFs are now cleaner and more efficient. Sections without data will be automatically hidden, allowing more patient data over a few days to fit on each page.

The glucose and statistics sections will always remain, and a single, comprehensive legend will now appear at the end of the report.

Smarter Defaults in the PDF Wizard for Hybrid Closed Loop Systems

Designed to streamline reporting workflows and help care teams quickly access the most meaningful insights, the Glooko PDF Wizard now automatically pre-selects the most relevant reports, including Summary, Week, Daily, and Devices, when a patient uses a Hybrid Closed Loop System like Omnipod® 5, Tandem t:slim X2 with Control-IQ technology, or mylife Loop powered by CamAPS® FX.

Care teams can still customize the selections as needed.

Enhanced Security in the Glooko Mobile App

At Glooko, we’re committed to the security and safety of our platform users.

People living with diabetes, including those under age 18, can now manage their login credentials (email and password) through a new Login Security section in the Glooko Mobile App’s Account Settings. We’ve also expanded support for two-factor authentication (2FA) to users to ensure an extra layer of protection.

Explore More Updates

For more detailed information about the new features designed to simplify diabetes management, be sure to check out the full release notes on the Glooko Support Center.

As healthcare providers, we find ourselves at a pivotal moment in diabetes management. Technological advances — from remote patient monitoring to artificial intelligence — have dramatically reshaped patient care. Yet, amid these innovations, a crucial element often remains overlooked: the voices of clinicians and people with diabetes.

In my new expanded role as Chief Medical and Strategy Officer at Glooko, I am excited about the opportunity to transition from direct patient care into a broader role where I can continue to make a significant impact on diabetes management and improve the lives of people with diabetes. I believe my firsthand clinical experience positions me uniquely to guide Glooko’s innovation efforts, ensuring we build tools that genuinely meet the needs of clinicians and people with diabetes alike.

In my nearly two decades as a pediatric endocrinologist, I’ve observed the profound potential—and the challenges—of integrating digital solutions into daily diabetes management. Clinicians routinely manage a complex array of tasks: reviewing glucose data from continuous glucose monitors (CGMs) or meters, adjusting insulin regimens, coaching patients on lifestyle, documenting clinical decisions, and coordinating across care teams. With a single person’s CGM device generating up to 288 data points per day, ¹ clinicians managing numerous people with diabetes face overwhelming workloads.

Individuals with diabetes echo similar concerns. Many describe data fatigue from constant management and analysis of their glucose levels. As one person stated, “The data is overwhelming; without clear insights and simpler ways to interpret it, it’s just noise.”

Although this wealth of data is invaluable, it contributes significantly to clinician burnout, and burn out among people with diabetes. Alarmingly, half to two-thirds of clinicians experience burnout, driven largely by bureaucratic tasks, extended working hours, and the sheer volume of data management.^2,3

Individuals with diabetes also report significant stress from managing their condition daily. Every glucose reading can feel like a pass or fail test. Effective technological integration could alleviate such emotional burdens by making data actionable, intuitive, and less intrusive.

At Glooko, we recognize that technology alone is not sufficient—it must seamlessly integrate into clinician workflows. Clinicians offer essential insights into behaviors of individuals, adherence barriers, and preferences. Unfortunately, many digital diabetes solutions miss the mark due to inadequate clinician input, leading to underutilization—only about 40% see active clinical use.⁴ Glooko addresses this by ensuring clinician insights directly shape our technology, streamlining workflow integration through interoperability with electronic health records (EHRs).

In a similar vein, simplicity and intuitive user experiences are paramount for people with diabetes to properly leverage diabetes management technologies. If the technology is complicated, it just becomes another barrier.

Today, our connected care platform exemplifies this integrated approach, merging patient-generated data with clinical decision-making tools. Evidence demonstrates connected care significantly improves diabetes outcomes, with reductions in HbA1c levels of up to 1.5% and fewer hypoglycemic events.⁵ Glooko enables clinicians to swiftly identify high-risk trends and proactively manage care for people with diabetes.

Tomorrow, AI-driven predictive analytics within Glooko could transform diabetes management by forecasting hypoglycemic and hyperglycemic events, facilitating timely, preventive interventions. Automating routine data analysis tasks can reduce clinicians’ documentation burdens by approximately 30%,^6,7 significantly alleviating stress and freeing clinicians to focus more deeply on clinical interactions. For people with diabetes, this can provide a significant improvement in their overall diabetes management.

I believe Glooko has immense potential, especially through advanced analytics and decision support. For instance, we could empower clinicians to shift from generalized treatment plans to highly personalized management strategies, grounded in timely data.

Innovation that is guided by those on the frontlines of care — people with diabetes and their care providers — is critical for meaningful advancements that can truly move the needle in diabetes care. In my role, I am dedicated to ensuring our solutions enhance workflows, support better outcomes, and ultimately bring a human-centric approach to diabetes management.

Together, we will define the future of diabetes care, directly addressing challenges clinicians face and improving the lives of those we treat. Here’s to a bright future ahead!

1. Speakman, ASHP. 2. Hammes et al., Endocrine News; Medscape Endocrinologist Lifestyle Report, 2022. 3. Batta et al., BMJ Open Diabetes Res Care. 4. Shah et al., J. Diabetes Sci Technol., 2023.5. Su et al., J. Med Internet Res., 2023. 6. AMA Digital Health Report. 7. Sidharthan et al., Scientific Reports, 2025.

At Glooko, we empower healthcare providers with the tools and insights they need to make informed decisions quickly and easily to improve the health outcomes of their patients living with diabetes.

With nearly half of physicians reporting at least one burnout symptom in a recent study from the American Medical Association, it’s critical we make diabetes data management simpler to not overburden those providing care.

That’s why the Glooko platform integrates with leading electronic health record (EHR) systems in the U.S., including Epic, Oracle Health, MEDITECH, Greenway Health, eClinicalWorks, NextGen, and Athenahealth, making our diabetes management platform seamlessly and securely available within this critical healthcare technology and eliminating the need to platform switch.

Why EHR Integrations Matter

Diabetes care is complex, and healthcare providers face the challenge of managing patient data across multiple systems. In an era where time is precious and clinicians are already spending much of their time on administrative tasks, clinicians need timely access to the most relevant health data without the inefficiencies of navigating multiple data platforms.

By integrating Glooko into EHRs, we streamline how healthcare providers access diabetes data, enabling them to provide the highest quality care. Our integrations provide clinicians and care teams with immediate access to comprehensive data from more than 200 diabetes and health monitoring devices used by their patients, eliminating the need for additional logins and manual data entry by people living with diabetes each day.

EHR integrations not only optimize existing systems, but they also have the potential to enhance clinical decision-making by giving clinicians the full picture of a person’s health. It empowers them to make faster, more informed treatment decisions. That’s why health systems spend $2.5 million to $1.2 billion on EHR integrations each year. They’re powerful and their care teams can reap the benefits of reduced documentation burden.

How It Works

By leveraging SMART on FHIR technology and HL7, standard interoperability frameworks, Glooko integrates with existing EHR systems at hospitals and health systems. Healthcare providers can then access patients’ timely glucose data, medication logs, activity levels, food intake, and much more without leaving the EHR.

The integrations support healthcare systems by offering a single, unified view of a person’s diabetes information, all while ensuring secure, HIPAA-compliant data exchange. The technology is designed to streamline workflows, making it easier for clinicians to focus on what truly matters: providing quality care for their patients.

A Step Toward the Future of Diabetes Care

Following the COVID-19 pandemic, clinical teams who provide care to the more than 38 million people in the U.S. living with diabetes have greatly declined in number, furthering the urgent need for seamless, data-driven solutions to help reduce administrative burdens and workloads that drive burnout.

• Since 2022, more than 138,000 nurses left the workforce due to stress, burnout, and retirement. New data from the NCSBN reveals almost 40% of nurses intend to leave the workforce by 2029, leaving the remaining time-pressed nurses to provide care to an already large patient population.
• Based on a recent GoodRx study, more than 70% of U.S. counties don’t have an endocrinologist and the number of trained endocrinologists is declining, meaning primary care providers must be knowledgeable in diabetes management and shoulder the workload.
• There is a significant shortfall of certified diabetes care and education specialists (CDCES), impacting diabetes care quality. In the U.S., there are about 19,500 diabetes educators — roughly 1 CDCES per 1,000 individuals with diabetes. An additional 35,000 educators would be required to meet the current demands of patients in the U.S. alone, furthering the workload burden.

And the burnout by clinicians and care teams is only going to grow greater as 98 million American adults have prediabetes, according to the CDC.

By optimizing and integrating with leading EHR systems, Glooko is taking a significant step forward in transforming diabetes management and reducing extra steps taken by healthcare providers to improve the quality of care. Our integrations help improve workflows, limit platform switching, simplify clinical decision-making, and support better outcomes for both healthcare providers and people with diabetes.

These integrations represent our ongoing commitment to delivering cutting-edge, interoperable solutions that empower both clinical teams and patients in making diabetes easier to manage.

Ready to Learn More?

Healthcare providers and hospital systems can access EHR integrations by reaching out to our dedicated team for a demo. With robust support from our dedicated team, some integrations, like with Epic, can be up and running within a weeks, making it easier than ever to take advantage of the benefits Glooko has to offer.

To learn more about Glooko’s many EHR integrations, visit our Integration Portal.